Follow RSS for latest reports on this topicHodgkin Lymphoma - Market Research and Reports

Hodgkin Lymphoma is a  disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be limited to a single lymph node region (Stage 1) or spread to other organs (Stage 4). Treatment with chemotherapy and radiotherapy has brought the 5 year survival rate to >95% for I-A type (asymptomatic type)

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...

or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma an [Report Updated: 24-04-2017]

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for 6 billion in 2015, and is anticipated to reach 9 billion by 2022, registering a CAGR of 6.8% from 2016 to 2022.nnOrphan drugs are used to treat rare (orphaned) diseases prevalent in a very small patie...Read More >>>


Published by: Allied Market Research

Prices Starting From:


Published by: Current Partnering

Prices Starting From:

Additional Searches

You may also like to search separately for: Hodgkin Lymphoma

We Stock...